1. High‐content imaging and structure‐based predictions reveal functional differences between Niemann‐Pick C1 variants
- Author
-
Ilpo Vattulainen, Lauri Vanharanta, Johan Peränen, Elina Ikonen, Simon G. Pfisterer, Giray Enkavi, Medicum, Department of Anatomy, Faculty of Medicine, STEMM - Stem Cells and Metabolism Research Program, Research Programs Unit, Institute of Biotechnology, Biosciences, University of Helsinki, Materials Physics, Department of Physics, Lipid Trafficking Lab, Tampere University, Physics, and Research group: Biological Physics and Soft Matter
- Subjects
congenital, hereditary, and neonatal diseases and abnormalities ,lipid droplets ,late endosomes ,Locus (genetics) ,Molecular Dynamics Simulation ,Biology ,114 Physical sciences ,gene variants ,Biochemistry ,03 medical and health sciences ,0302 clinical medicine ,Niemann-Pick C1 Protein ,Structural Biology ,cholesterol transport ,hemic and lymphatic diseases ,Lipid droplet ,Complementary DNA ,Genetics ,Niemann-Pick C1 ,Humans ,CRISPR ,lysosomal storage diseases ,Molecular Biology ,Gene ,030304 developmental biology ,chemistry.chemical_classification ,0303 health sciences ,Intracellular Signaling Peptides and Proteins ,Proteins ,nutritional and metabolic diseases ,Biological Transport ,217 Medical engineering ,Cell Biology ,Amino acid ,Cell biology ,Cholesterol ,chemistry ,GenBank ,1182 Biochemistry, cell and molecular biology ,lipids (amino acids, peptides, and proteins) ,3111 Biomedicine ,NPC1 ,Lysosomes ,030217 neurology & neurosurgery - Abstract
The human Niemann-Pick C1 (NPC1) gene encoding a 1278 amino acid protein is very heterogeneous. While some variants represent benign polymorphisms, NPC disease carriers and patients may possess rare variants, whose functional importance remains unknown. An NPC1 cDNA construct known as NPC1 wild-type variant (WT-V), distributed between laboratories and used as a WT control in several studies, also contains changes regarding specific amino acids compared to the NPC1 Genbank reference sequence. To improve the dissection of subtle functional differences, we generated human cells stably expressing NPC1 variants from the AAVS1 safe-harbor locus on an NPC1-null background engineered by CRISPR/Cas9 editing. We then employed high-content imaging with automated image analysis to quantitatively assess LDL-induced, time-dependent changes in lysosomal cholesterol content and lipid droplet formation. Our results indicate that the L472P change present in NPC1 WT-V compromises NPC1 functionality in lysosomal cholesterol export. All-atom molecular dynamics simulations suggest that the L472P change alters the relative position of the NPC1 middle and the C-terminal luminal domains, disrupting the recently characterized cholesterol efflux tunnel. These results reveal functional defects in NPC1 WT-V and highlight the strength of simulations and quantitative imaging upon stable protein expression in elucidating subtle differences in protein function. publishedVersion
- Published
- 2020